Lineage Cell Therapeutics Inc (LCTX)
AMEX
Quarter End | 12 2022 | 3 2023 | 6 2023 | 9 2023 | 12 2023 | 3 2024 | 6 2024 | 9 2024 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
総資産 | 123.66M | 113.21M | 111.69M | 106.15M | 101.02M | 108.48M | 102.8M | 96.59M |
流動資産合計 | 60M | 49.66M | 48.49M | 43.48M | 38.44M | 45.72M | 40.39M | 34.4M |
現金および同等物 | 11.36M | 15.45M | 33.89M | 31.47M | 35.44M | 43.58M | 29.62M | 27.75M |
非流動資産合計 | 69.34M | 69.13M | 68.51M | 67.53M | 67.35M | 64.87M | 64.43M | 64.21M |
負債合計 | 51.73M | 44.19M | 40.43M | 39.49M | 39M | 37.49M | 35.93M | 31.8M |
流動負債合計 | 18.98M | 17.23M | 16.05M | 15.88M | 17.96M | 16.89M | 15.28M | 13.86M |
非流動負債合計 | 32.83M | 27.1M | 24.49M | 23.71M | 21.13M | 20.68M | 20.72M | 18.02M |
普通株 | 440.28M | 441.3M | 448.25M | 450.28M | 451.34M | 466.57M | 467.93M | 469.27M |
留保所得 | -363.37M | -367.74M | -372.97M | -380.08M | -384.86M | -391.4M | -397.16M | -2.89M |
年末 2023年12月31日 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
総資産 | 142.57M | 173.24M | 101.66M | 125.48M | 107.95M | 174.55M | 123.66M | 101.02M |
流動資産合計 | 25.65M | 42.62M | 36.36M | 57.52M | 44M | 111.55M | 60M | 38.44M |
現金および同等物 | 22.09M | 36.84M | 23.59M | 9.5M | 32.59M | 55.74M | 11.36M | 35.44M |
非流動資産合計 | 130.51M | 164.26M | 92.25M | 111.25M | 95.13M | 90.9M | 71.94M | 62.02M |
負債合計 | 12.06M | 8.98M | 9.41M | 14.23M | 12.82M | 83.65M | 51.73M | 39M |
流動負債合計 | 8.85M | 6.88M | 6.81M | 6.49M | 7.77M | 47.12M | 18.98M | 17.96M |
非流動負債合計 | 6.06M | 3.27M | 4.56M | 7.81M | 5.08M | 36.56M | 32.83M | 21.13M |
総資本 | 130.51M | 164.26M | 92.25M | 111.25M | 95.13M | 90.9M | 71.94M | 62.02M |
普通株 | 317.88M | 378.49M | 354.27M | 387.06M | 393.94M | 434.53M | 440.28M | 451.34M |
留保所得 | -196.32M | -216.3M | -261.86M | -273.42M | -294.08M | -337.1M | -363.37M | -384.86M |
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約